Compares survival and toxicity in adult granulosa cell tumor, suggesting treatment optimization.
Adult granulosa cell tumors (AGCTs) are rare ovarian sex cord-stromal tumors, and the role of adjuvant chemotherapy remains uncertain. We compared disease-free survival (DFS) and toxicity between bleomycin-etoposide-cisplatin/etoposide-cisplatin (BEP/EP) and carboplatin-paclitaxel (CP).
No takes yet. Share an insight, caveat, or question.
Gecgel et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: